Clinical Trials
29 trialsIACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors
M.D. Anderson Cancer Center
A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer
Cancer Research UK
Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial
Fred Hutchinson Cancer Center
PNeoVCA
Mayo Clinic
EMITT-1
Grey Wolf Therapeutics
HPV-E6-Specific Anti-PD1 TCR-T Cells in the Treatment of HPV-Positive NHSCC or Cervical Cancer
Xinqiao Hospital of Chongqing
Potlako+
Brigham and Women's Hospital
Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors
University of Pittsburgh
A Study of GV20-0251 in Advanced or Refractory Solid Tumors
West China Hospital
NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours
NuCana plc
ACROPOLI
SOLTI Breast Cancer Research Group
PEVOsq
UNICANCER
VolATIL
Centre Hospitalier Universitaire de Besancon
A Clinical Study of Anti-CD70 UCAR-T in Relapsed or Refractory Solid Tumors
Zhejiang University
Patient Reported Outcomes Study Using Electronic Monitoring System for Advanced or Metastatic Solid Cancer
Comprehensive Support Project for Oncology Research
Myeloprotection With Trilaciclib in Pan-cancer Population
Sun Yat-sen University
UPLIFT
Massachusetts General Hospital
Arginase-1 Peptide Vaccine in Patients With Metastatic Solid Tumors
Herlev Hospital
Selecting Chemotherapy With High-throughput Drug Screen Assay Using Patient Derived Organoids in Patients With Refractory Solid Tumours (SCORE)
National University Hospital, Singapore
IOSI-NDU-001
Oncology Institute of Southern Switzerland
High-dose ICE With Amifostine
Dana-Farber Cancer Institute
OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer
OHSU Knight Cancer Institute
Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors
Dartmouth-Hitchcock Medical Center
Chemotherapy in Treating Patients With Solid Tumors
Memorial Sloan Kettering Cancer Center
Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer
Memorial Sloan Kettering Cancer Center
Dimesna in Treating Patients With Solid Tumors Who Are Undergoing Treatment With Cisplatin and Paclitaxel
Roswell Park Cancer Institute
Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor
Vanderbilt-Ingram Cancer Center
Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer
Hoag Memorial Hospital Presbyterian
Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function
City of Hope Medical Center